Oral semaglutide in kidney transplant recipients with metabolic syndrome: three Japanese cases.
Not Applicable
- Conditions
- Kidney transplant recipients with metabolic syndrome
- Registration Number
- JPRN-UMIN000050853
- Lead Sponsor
- Fujita Memorial Hospital
- Brief Summary
Three renal transplant recipients with metabolic syndrome received oral semaglutide for 12 months. All patients lost weight and had no change in eGFR.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 3
Inclusion Criteria
Not provided
Exclusion Criteria
Insulin user
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Change in body weight after 12 months of oral semaglutide administration
- Secondary Outcome Measures
Name Time Method Change in eGFR 12 months after initiation of oral semaglutide